The global facial rejuvenation market size was valued at USD 22.47 billion in 2025 and is projected to grow from USD 23.15 billion in 2026 to USD 29.32 billion by 2034 at a CAGR of 3% during the forecast period 2026-2034.
Facial rejuvenation is a medical cosmetic treatment procedure that is aimed to restore the youthful physical appearance of the face. These facial rejuvenation techniques can be either surgical or non-surgical and can be used for the treatment of static wrinkles, freckles, dynamic wrinkles, vascular conditions, scars and wounds, and pigmentation. Naturally, with the process of aging, the facial skin loses subcutaneous fat, and thus, is pulled closer to the facial working muscles, resulting in smile lines and wrinkles over the face. These issues can be rectified by using facial rejuvenation products such as injectables or dermal fillers which are provenly effective in treating early signs of aging.
Download Free Sample Report to Get Detailed Insights.
There has been a growing number of people across the globe who belong to the middle-aged and geriatric age bracket. These people are recognized as the most frequent consumers of market products. Thus, the growing number of people in the aforementioned age bracket generates huge demand for market products. For instance, according to reports suggested by Eurostat, the median age in Europe is 42.5 years in 2020 that rose from constant 41.7 years in 2019, 2018, and 2017 respectively. Further, statistics suggest that around 66.4 percent between the ages of 15 and 64 years in Mexico. Further, as per Statistics Canada, 40-43% of the population is estimated to be in the age bracket of 25-54 years.
Table 1: The U.S. Population Demographics Projection Data (65 Years and Over): 2020 to 2060
Year of Estimate
Total population 65 years and over (number in thousands)
Native-born population 65 years and over (number in thousands)
Foreign-born population 65 years and over
2020
56,052
48,034
8,017
2030
73,138
60,849
12,289
2040
80,827
64,268
16,559
2050
85,675
65,838
19,837
2060
94,676
72,652
22,024
**Source: 2020 to 2060; National Population Projections2017.
Thus, as per projections, since a huge number of estimated people are expected to be in the age bracket of 65years and older in the coming future, it can be predicted that a major proportion of people currently belong to the age group of 45-60 years. Thus, quite evidently, the market is projected to be significantly boosted during the study period owing to such a consumer base.
During the past few years, there has been rising adoption of cosmetic facial rejuvenation techniques. This is primarily due to growing beauty consciousness among consumers, growing need to maintain physical presentability. Further, there is a huge number of professionals in professions that demand long-lasting youthful appearances especially in the facial regions such as actors, dancers, models, sportsmen, and others.
Table 2: Total Surgical Aesthetic Procedures across the Globe During 2019-2018
Total Surgical Procedures
2019
2018
Percent Change 2019 Vs. 2018
Brow Lift
270,917
220,055
23.1%
Ear Surgery
288,905
262,078
10.2%
Eyelid Surgery
1,259,839
1,099,960
14.5%
Facelift
448,485
398,798
12.5%
Facial Bone Contouring
108,536
98,727
9.9%
Fat Grafting-face
598,823
542,305
10.4%
Facial Rejuvenation
4,058,143
3,574,408
13.5%
*Source: International Society of Aesthetic Plastic Surgery; Global Survey 2019
Table 3: Total Non-Surgical Aesthetic Procedures across the Globe During 2019-2018
Chemical Peel
369,497
408,485
-9.5%
Full Field Ablative
190,978
192,880
-1.0%
Micro-Ablative Resurfacing
270,759
201,797
34.2%
Photo Rejuvenation
391,415
436,656
-10.4%
Total Facial Rejuvenation
1,222,648
1,239,819
-1.4%
Thus, owing to the aforementioned factors there has been a growing number of aesthetic enhancement procedures that ultimately boost the market.
Further, the market growth is also fueled owing to continuous efforts from market players to launch new products as well as strategies to penetrate unexplored markets. For instance, InMode MD Ltd. has been conducting a clinical trial on energy-based lower eyelid rejuvenation using its novel InModeAccuTite device expected to be completed by 2021.
Within the global facial rejuvenation market, the dermal filler product segment generates the highest revenue amongst others. This market dominance can be attributed to the fact that, when compared to traditional cosmetic surgeries, these fillers are proven to be more reliable, easy-going, affordable, and cost-effective. For instance, according to the American Society of Plastic Surgeons, in the year 2018, the basic fees charged by cosmetic or plastic surgeons for a facelift surgery was at an aggregate of USD 7655, whereas, the cost of the same using dermal fillers such as hyaluronic acid was estimated to be approximately USD 682 in the U.S. Thus, quite naturally, there is an increasing the bias towards the adoption of dermal fillers.
Further, most of the consumers are very aware and conscious about the products they use, and hence towing to this, many consumers prefer prescription-based facial rejuvenation products such as dermal fillers that have clinically proven record for safety and effectiveness. Thus, there has been an increase in the adoption of these products that are enhancing the growth of the facial rejuvenation market.
By End-users, the Dermatology clinics segment market is expected to hold the majority of the market and is further anticipated to progress at a steady pace over the projected timeframe. This high growth projectile is primarily due to the high preference among consumers to opt for these clinics. Further, these clinics provide generous treatment options and thus witness fueled growth.
However, the hospitals and clinics segment is anticipated to demonstrate the highest growth rate owing to the increasing consumer pool who seek these treatments. Thus, owing to the presence of large spaces and supporting infrastructure, a greater number of trained personnel, the segment is witnessing growth.
The American regional market contributes a significant number to the global revenue. This is because there is a huge number of professionals within the region who are active in show businesses such as Actors, dancers, models, sportsmen, and others. Further, the presence of the Hollywood industry in the region that worth in billion operates on aesthetics, generates huge demands for these market products and contributes significantly to totals spending on cosmetic products.
Additionally, high disposable income, growing beauty among common people, and the increasing importance of physical appearance in presentability are other drivers of the market. The majority of the regional population has a high average income which makes this facial rejuvenation and medical aesthetics products affordable, which is also predicted to boost the market growth. For instance, as per the American Society for Aesthetic Plastic Surgery (ASAPS), Americans invested around USD 13500 million on aesthetic procedures in 2015 and further an estimated amount of more than USD 15000 million in 2016. Further, the great number of aesthetic procedures that are carried out in the region boosts the regional market.
Table 4: Total Number of Aesthetic Non-surgical Procedures in the Americas in 2019
Treatment Category
USA
BRAZIL
MEXICO
ARGENTINA
Botulinum Toxin
1,301,823
507,869
287,420
76,802
Calcium Hydroxylapatite
37,881
29,694
14,762
3,971
Hyaluronic Acid
679,167
398,830
170,515
61,831
73,347
34,804
14,783
3,201
30,360
15,088
10,047
3,234
69,621
12,503
9,962
Total Facial Rejuvenation Procedure
276,069
86,438
58,580
31,405
Asia-Pacific market is expected to show high growth during the aforementioned market forecast period. The market growth is predominantly owing to the shifting focus to better facial aesthetics and appearance among people. The people with these growing beauty concerns can be traced to the mid-age population and elderly age brackets. Thus, the pronounced presence of the aforementioned population segment is driving the facial rejuvenation market in Asia-Pacific. For instance, it is estimated that approximately 48.42% of the total population of China was aged between 25 to 54 years with the highest numbers in Shanghai and Beijing. Further, the growing number of facial rejuvenation procedures in the region is also significantly boosting the regional market.
Further, owing to the presence of a huge population such as China and India, these countries are often targeted markets for global market leaders. For instance, market leaders Allergans launched Juvederm Volite Dermal Filler in India on January 19th, 2020 targeting to explore a huge population and thus, consumer base in the Indian Market. Further, in October 2019, InMode Ltd. has successfully established two new subsidiaries in the Asia-Pacific region namely; InMode India and InMode Australia.
Table 5: Total cosmetic non-surgical treatments conducted in India (2019)
Injectables
Number of Procedures
% Of Total Global
Total Injectables Procedures
113,616
45.6%
Total Facial Rejuvenation Procedures
80,304
32.2%
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com